ID
Osteomyelitis Management
search
Osteomyelitis Management
, Cierny-Mader Staging System
See Also
Osteomyelitis
Osteomyelitis Causes
Vertebral Osteomyelitis
Osteomyelitis Management in Diabetes Mellitus
Staging
Cierny-Mader Staging System
Anatomic Type
Stage 1:
Medulla
ry
Osteomyelitis
Stage 2: Superficial
Osteomyelitis
Stage 3: Localized
Osteomyelitis
Stage 4: Diffuse
Osteomyelitis
Physiologic Type
Class A: Normal
Immune System
response and healthy vascular system
Class B-L: Compromised locally
Arteritis
Lymphedema
Radiation Fibrosis
Tissue scarring
Vascular Compromise (e.g.
Peripheral Arterial Disease
,
Critical Limb Ischemia
)
Venous Stasis
Class B-S: Compromised systemically
Alcohol Abuse
Age extremes (young children, elderly)
Chronic
Hypoxia
Corticosteroid
Use
Diabetes Mellitus
Immunodeficiency
Malignancy
Malnutrition
Liver
Failure
Renal Failure
Tobacco Abuse
Class C: Not a surgical candidate
Treatment is more harmful than disease
Palliative management is indicated
References
Marais (2015) J Orthop 12(4): 184-92 +PMID: 26566317 [PubMed]
Management
Gene
ral
If possible, delay
Antibiotic
s until bone culture and sensitivity are available
Indications for empiric immediate
Antibiotic
s (prior to biopsy, culture results)
Hospitalized patients at risk of
MRSA
Severe
Sepsis
Epidural Abscess
Neurologic involvement
Bone biopsy and surgical
Debridement
Indications
Indicated in most cases of
Chronic Osteomyelitis
and contiguous infection
Underlying orthopedic hardware
Necrotic bone
Protocol
Bone stabilization is performed at time of
Debridement
Consider
Antibiotic
-loaded
Collagen
sponge placement
Van Vugt (2008) J Bone Joint Surg Am 100(24): 2153-61 [PubMed]
Efficacy
Decreases hospital stays,
Antibiotic
therapy duration and prevents complications
Shih (2005) J Trauma 58(1): 83-7 [PubMed]
Once obtaining surgical bone culture-based
Antibiotic
sensitivities, oral
Antibiotic
s are as effective as
Parenteral
Rombach (2019) N Engl J Med 380(5):425-36 [PubMed]
Additional Measures
Hyperbaric Oxygen Therapy
Savvidou (2018) Orthopedics 41(4): 193-9 [PubMed]
Management
Acute (Hematogenous Spread)
Protocol
Total
Antibiotic
duration: 4 to 6 weeks (up to 3-6 months for prosthetic hip or knee)
Parenteral
Antibiotic
s for first 1-2 weeks
Oral
Antibiotic
s for remainder of course
Obtain cultures before starting empiric
Antibiotic
s
Revise
Antibiotic
coverage upon culture results
First-line
Antibiotic
s (choose 2)
Antibiotic
1:
Vancomycin
Vancomycin
substitutes:
Linezolid
,
Daptomycin
, Trimethoprim-Sulfamethoxazole or if sensitive,
Clindamycin
Cefazolin
or
Nafcillin
may be considered instead in non-life threatening infecton if low
MRSA
risk (<10%)
Antibiotic
2:
Cephalosporin
(
Ceftriaxone
,
Ceftazidime
,
Cefepime
,
Cefotaxime
)
Cephalosporin
substitutes:
Aztreonam
, or if over age 15 years,
Ciprofloxacin
or
Levofloxacin
Additional coverage in special circumstances
Sickle Cell Anemia
(include
Salmonella
coverage)
Add
Fluoroquinolone
(avoid in children, unless directed by infectious disease consultant)
IV Drug Abuse
or
Hemodialysis
patient (polymicrobial infections)
Add
Ciprofloxacin
Immunocompromised
patients
Consider broadening coverage to include fungal organisms (e.g. candida) and
Mycobacterium
species
Other specific management (based on cultures)
Candida Albicans
Surprisingly, most often occurs in immunocompetent patients
Most common sites are
Vertebra
e in adults, the femur in children
Surgical
Debridement
and hardware removal is typical
Treated with
Antifungal
s for 6-12 months
IV for First 2 weeks:
Echinocandin
(e.g.
Caspofungin
),
Fluconazole
or
Amphotericin B
Next:
Fluconazole
for 6-12 months
Gamaletsou (2012) Clin Infect Dis 55(10):1338-51 +PMID:22911646 [PubMed]
Management
Contiguous
Osteomyelitis
No Vascular Insufficiency
Bacteria
l causes
Staphylococcus aureus
Coagulase Negative
Staphylococcus
Gram Negative Rod
s
Streptococcus
Pseudomonas
aeruginosa
Empiric
Antibiotic
s (only in acutely ill patients, otherwise wait for culture results)
Vancomycin
(or
Linezolid
) AND
Cephalosporin
(
Ceftazidime
or
Cefepime
)
Consider adding
Rifampin
Prosthetic joint
Spinal implant
Antibiotic
s after culture identifies
Bacteria
Methicillin
sensitive
Staphylococcus aureus
First-line:
Nafcillin
,
Oxacillin
,
Cefazolin
Methicillin Resistant Staphylococcus Aureus
First-line:
Vancomycin
Alternative:
Linezolid
,
Rifampin
,
Daptomycin
Streptococcus
Species
First-Line:
Penicillin G
Alternatives:
Ceftriaxone
,
Clindamycin
Quinolone
-Resistant
Enterobacteriaceae
First-Line:
Ticarcillin
/Clavulanate (
Timentin
),
Piperacillin
/Tazobactam (
Zosyn
)
Alternatives:
Ceftriaxone
Quinolone
-Sensitive
Enterobacteriaceae
First-Line:
Fluoroquinolone
(e.g.
Ciprofloxacin
,
Levofloxacin
)
Alternatives:
Ceftriaxone
Pseudomonas
aeruginosa
First-Line:
Ciprofloxacin
AND
Cefepime
or
Piperacillin
/Tazobactam (
Zosyn
)
Alternative:
Imipenem
/Cilastin (
Primaxin
) AND
Aminoglycoside
Anaerobic Bacteria
First-Line:
Clindamycin
,
Ticarcillin
/Clavulanate (
Timentin
)
Alternative:
Cefotetan
(
Cefotan
),
Metronidazole
(
Flagyl
)
Antibiotic
course
Duration if no hardware: 6-8 weeks
Duration if hardware: 3-6 months (or until hardware removed)
Vascular Insufficiency (
Peripheral Arterial Disease
or
Diabetes Mellitus
with
Neuropathy
)
See
Diabetic Foot Infection
See
Diabetic Foot Osteomyelitis
Antibiotic
s for 6 weeks based on bone culture and sensitivity
Empiric
Antibiotic
s (only in acutely ill patients, otherwise wait for culture results)
Vancomycin
AND
Ertapenem
(or
Moxifloxacin
)
Other measures
Consider revascularization
Management
Chronic Osteomyelitis
Avoid Empiric
Antibiotic
s unless acute exacerbation
Treat acute exacerbation as
Acute Osteomyelitis
Base management on culture and sensitivity
Bone biopsy culture and sensitivity (preferred)
Soft-tissue culture and sensitivity
Antibiotic
duration for 2 to 6 weeks
Surgical
Debridement
with
Careful and complete
Debridement
is critical
Dead-space management
Local myoplasty
Free-tissue transfers
Antibiotic
impregnated beads
References
(2019) Sanford Guide, accessed on IOS 10/26/2019
Bamberger (2005) Am Fam Physician 72:2471-81 [PubMed]
Boutin (1998) Orthop Clin North Am 29:41-66 [PubMed]
Bury (2021) Am Fam Physician 104(4): 395-402 [PubMed]
Carek (2001) Am Fam Physician 63(12):2413-20 [PubMed]
Hatzenbuehler (2011) Am Fam Physician 84(9): 1027-33 [PubMed]
Lew (1997) N Engl J Med 336:999-1007 [PubMed]
Lipsky (1997) Clin Infect Dis 25:1318-26 [PubMed]
Type your search phrase here